Gerard M - Search Results

1

FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.

Gerard M, Debyser Z, Desender L, Baert J, Brandt I, Baekelandt V, Engelborghs Y. Gerard M, et al. J Neurochem. 2008 Jul;106(1):121-33. doi: 10.1111/j.1471-4159.2008.05342.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18346205 Free article.

2

The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy.

Gerard M, Debyser Z, Desender L, Kahle PJ, Baert J, Baekelandt V, Engelborghs Y. Gerard M, et al. FASEB J. 2006 Mar;20(3):524-6. doi: 10.1096/fj.05-5126fje. Epub 2006 Jan 12. FASEB J. 2006. PMID: 16410343 Free article.

3

Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.

Gerard M, Deleersnijder A, Daniëls V, Schreurs S, Munck S, Reumers V, Pottel H, Engelborghs Y, Van den Haute C, Taymans JM, Debyser Z, Baekelandt V. Gerard M, et al. J Neurosci. 2010 Feb 17;30(7):2454-63. doi: 10.1523/JNEUROSCI.5983-09.2010. J Neurosci. 2010. PMID: 20164329 Free PMC article.

4

The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.

Meuvis J, Gerard M, Desender L, Baekelandt V, Engelborghs Y. Meuvis J, et al. Among authors: gerard m. Biochemistry. 2010 Nov 2;49(43):9345-52. doi: 10.1021/bi1010927. Biochemistry. 2010. PMID: 20828147

5

Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.

Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buée L, Debyser Z, Baekelandt V, Gerard M. Deleersnijder A, et al. Among authors: gerard m. J Biol Chem. 2011 Jul 29;286(30):26687-701. doi: 10.1074/jbc.M110.182303. Epub 2011 Jun 7. J Biol Chem. 2011. PMID: 21652707 Free PMC article.

6

The remarkable conformational plasticity of alpha-synuclein: blessing or curse?

Deleersnijder A, Gerard M, Debyser Z, Baekelandt V. Deleersnijder A, et al. Among authors: gerard m. Trends Mol Med. 2013 Jun;19(6):368-77. doi: 10.1016/j.molmed.2013.04.002. Epub 2013 May 3. Trends Mol Med. 2013. PMID: 23648364 Review.

7

In vitro phosphorylation does not influence the aggregation kinetics of WT α-synuclein in contrast to its phosphorylation mutants.

Schreurs S, Gerard M, Derua R, Waelkens E, Taymans JM, Baekelandt V, Engelborghs Y. Schreurs S, et al. Among authors: gerard m. Int J Mol Sci. 2014 Jan 15;15(1):1040-67. doi: 10.3390/ijms15011040. Int J Mol Sci. 2014. PMID: 24434619 Free PMC article.

8

Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein.

Brandt I, Gérard M, Sergeant K, Devreese B, Baekelandt V, Augustyns K, Scharpé S, Engelborghs Y, Lambeir AM. Brandt I, et al. Among authors: gerard m. Peptides. 2008 Sep;29(9):1472-8. doi: 10.1016/j.peptides.2008.05.005. Epub 2008 May 15. Peptides. 2008. PMID: 18571285

9

Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.

Verhaar R, Jongenelen CA, Gerard M, Baekelandt V, Van Dam AM, Wilhelmus MM, Drukarch B. Verhaar R, et al. Among authors: gerard m. Neurochem Int. 2011 Jun;58(7):785-93. doi: 10.1016/j.neuint.2011.03.004. Epub 2011 Mar 31. Neurochem Int. 2011. PMID: 21440023

10

Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Gerard M, Deleersnijder A, Demeulemeester J, Debyser Z, Baekelandt V. Gerard M, et al. Mol Neurobiol. 2011 Aug;44(1):13-27. doi: 10.1007/s12035-011-8184-2. Epub 2011 May 7. Mol Neurobiol. 2011. PMID: 21553017 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

597 results

Search Page

Filters